Incidence of severe mucositis was decreased in palifermin patients, albeit it did not reach statistical significance (p = 0.6).
← all excerpts
Palifermin for management of treatment-induced oral mucositis in cancer patients.
1
0.6000
0.6000
Incidence of severe mucositis was decreased in palifermin patients, albeit it did not reach statistical significance (p = 0.6).